University of California - Davis, Comprehensive Cancer Center — Davis, California

University of California - Davis, Comprehensive Cancer Center is a clinical research site located in Davis, California, United States 95817.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

University of California - Davis, Comprehensive Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasms, Breast Cancer, Breast Tumors.

Sponsors: QuantumLeap Healthcare Collaborative.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Davis

Browse all research sites in California · View every site in Davis

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California - Davis, Comprehensive Cancer Center?

University of California - Davis, Comprehensive Cancer Center has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California - Davis, Comprehensive Cancer Center conducted?

University of California - Davis, Comprehensive Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms, Breast Cancer, Breast Tumors.

Is University of California - Davis, Comprehensive Cancer Center accredited by Crixeo Clinical Trials?

University of California - Davis, Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California - Davis, Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.